Explore the words cloud of the EULAT Eradicate GBC project. It provides you a very rough idea of what is the project "EULAT Eradicate GBC" about.
The following table provides information about the project.
|Coordinator Country||Germany [DE]|
|Total cost||4˙675˙932 €|
|EC max contribution||4˙675˙932 € (100%)|
1. H2020-EU.3.1.3. (Treating and managing disease)
|Duration (year-month-day)||from 2019-12-01 to 2025-11-30|
Take a look of project's partnership.
|1||UNIVERSITATSKLINIKUM HEIDELBERG||DE (HEIDELBERG)||coordinator||2˙362˙344.00|
|2||OSLO UNIVERSITETSSYKEHUS HF||NO (OSLO)||participant||762˙500.00|
|3||UNIVERSIDAD DE CHILE||CL (SANTIAGO)||participant||571˙000.00|
|4||UNIVERSITY OF BRISTOL||UK (BRISTOL)||participant||126˙337.00|
|5||INSTITUTO NACIONAL DE ENFERMEDADES NEOPLASICAS-INEN||PE (LIMA)||participant||125˙000.00|
|6||SANATORIO EL CARMEN SA||AR (SALTA)||participant||125˙000.00|
|7||Universidad Austral de Chile||CL (VALDIVIA)||participant||125˙000.00|
|8||UNIVERSIDAD CATÓLICA DEL MAULE||CL (TALCA)||participant||125˙000.00|
|9||UNIVERSIDAD DE LA FRONTERA||CL (TEMUCO)||participant||125˙000.00|
|10||UNIVERSIDAD MAYOR DE SAN SIMON||BO (COCHABAMBA)||participant||125˙000.00|
|11||PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE||CL (SANTIAGO)||participant||62˙500.00|
|12||KLINIKUM DER JOHANN WOLFGANG VON GOETHE UNIVERSITAET||DE (FRANKFURT AM MAIN)||participant||41˙250.00|
|13||CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER||FR (LYON CEDEX 08)||participant||0.00|
Gallbladder cancer (GBC) is a neglected disease with huge potential for prevention. This project aims at significantly improving the accuracy of risk estimation and early detection of GBC by identifying and adequately considering geographical, environmental, lifestyle, ethnic, gender and molecular differences. We plan to generate the information needed to establish and refine current prevention programmes, including the primary, secondary and tertiary prevention of GBC. We will (1) build a unique European–Latin American GBC biorepository integrated into a tailored IT platform, (2) identify, validate and functionally characterize novel GBC biomarkers, (3) develop a multifactorial risk score that integrates established and newly identified epidemiological and molecular risk factors, (4) improve the understanding of the causal mechanisms that link lifestyle, cultural and behavioural factors to GBC development, (5) unravel novel opportunities for the targeted therapy of incidental GBC, (6) exploit existing and newly generated epidemiological and multi-omics data to improve the accuracy of GBC risk prediction and (7) contribute to the training of the next generation of Latin American researchers in precision medicine for GBC. The generated information will permit identification of individuals at high GBC risk, guiding surveillance and individual decisions on the possible benefit of preventive gallbladder removal in regions of low and high GBC incidence. Novel data on genomic alterations in incidental GBC will pave the way towards implementation of future clinical trials. The planned European–Latin American GBC biorepository and IT platform will constitute a prime resource for translational research on individualized prevention, personalized early detection and targeted therapy of GBC. The participation in our project of representatives of health authorities, patients and the industry guarantees the efficient incorporation of project results into national health policies.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EULAT ERADICATE GBC" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "EULAT ERADICATE GBC" are provided by the European Opendata Portal: CORDIS opendata.
PanCareFollowUp: Novel, patient-centred survivorship care to improve care quality, effectiveness, cost-effectiveness and accessibility for survivors and caregiversRead More
ENDOSCAPE, a clinically applicable non-viral gene delivery technologyRead More
Childhood Leukemia: Overcoming distance between South America and Europe RegionsRead More